PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29733511-7	2018	Lenvatinib also exerted antitumor activity and potently reduced tumor microvessel density in PLC/PRF/5 xenograft model and two HCC patient-derived xenograft models.	lenvatinib	0-10	heparan sulfate proteoglycan 2	Homo sapiens	93-96	
32655838-9	2020	LEN significantly inhibited more LEN-related signal transduction pathways in PLC/PRF5 than in PLC/PRF5-R2 cells.	lenvatinib	0-3	heparan sulfate proteoglycan 2	Homo sapiens	77-80	
32655838-9	2020	LEN significantly inhibited more LEN-related signal transduction pathways in PLC/PRF5 than in PLC/PRF5-R2 cells.	lenvatinib	33-36	heparan sulfate proteoglycan 2	Homo sapiens	77-80